Level of inflammatory cytokines tumour necrosis factor , interleukins 12, 23 and 17 in patients with psoriasis in the context of metabolic syndrome

Magdalena Pirowska; Katarzyna Podolec; Sylwia Lipko-Godlewska; Joanna Sułowicz; Paweł Brzewski; Aleksander Obtułowicz; Maciej Pastuszczak; Anna Wojas-Pelc

doi:10.5114/ada.2018.73136

eISSN: 2299-0046
ISSN: 1642-395X

Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2019
vol. 36

Send email

Copy url:

abstract:

Original paper

Level of inflammatory cytokines tumour necrosis factor , interleukins 12, 23 and 17 in patients with psoriasis in the context of metabolic syndrome

Magdalena Pirowska

,

Katarzyna Podolec

,

Sylwia Lipko-Godlewska

,

Joanna Sułowicz

,

Paweł Brzewski

,

Aleksander Obtułowicz

,

Maciej Pastuszczak

,

Anna Wojas-Pelc

Adv Dermatol Allergol 2019; XXXVI (1): 70-75

DOI: https://doi.org/10.5114/ada.2018.73136

Online publish date: 2018/02/02

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Pirowska M, Podolec K, Lipko-Godlewska S, et al. Level of inflammatory cytokines tumour necrosis factor , interleukins 12, 23 and 17 in patients with psoriasis in the context of metabolic syndrome. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2019;36(1):70-75. doi:10.5114/ada.2018.73136.

APA

Pirowska, M., Podolec, K., Lipko-Godlewska, S., Sułowicz, J., Brzewski, P.,  & Obtułowicz, A. et al. (2019). Level of inflammatory cytokines tumour necrosis factor , interleukins 12, 23 and 17 in patients with psoriasis in the context of metabolic syndrome. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 36(1), 70-75. https://doi.org/10.5114/ada.2018.73136

Chicago

Pirowska, Magdalena, Katarzyna Podolec, Sylwia Lipko-Godlewska, Joanna Sułowicz, Paweł Brzewski, Aleksander Obtułowicz,  and Maciej Pastuszczak et al. 2019. "Level of inflammatory cytokines tumour necrosis factor , interleukins 12, 23 and 17 in patients with psoriasis in the context of metabolic syndrome". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 36 (1): 70-75. doi:10.5114/ada.2018.73136.

Harvard

Pirowska, M., Podolec, K., Lipko-Godlewska, S., Sułowicz, J., Brzewski, P., Obtułowicz, A., Pastuszczak, M.,  and Wojas-Pelc, A. (2019). Level of inflammatory cytokines tumour necrosis factor , interleukins 12, 23 and 17 in patients with psoriasis in the context of metabolic syndrome. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 36(1), pp.70-75. https://doi.org/10.5114/ada.2018.73136

MLA

Pirowska, Magdalena et al. "Level of inflammatory cytokines tumour necrosis factor , interleukins 12, 23 and 17 in patients with psoriasis in the context of metabolic syndrome." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 36, no. 1, 2019, pp. 70-75. doi:10.5114/ada.2018.73136.

Vancouver

Pirowska M, Podolec K, Lipko-Godlewska S, Sułowicz J, Brzewski P, Obtułowicz A et al. Level of inflammatory cytokines tumour necrosis factor , interleukins 12, 23 and 17 in patients with psoriasis in the context of metabolic syndrome. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2019;36(1):70-75. doi:10.5114/ada.2018.73136.

Introduction
Psoriasis is a chronic inflammatory skin disease with immunologic etiology.

Aim
To investigate the levels of the proinflammatory cytokines tumor necrosis factor  (TNF-), interleukin 23 (IL-23) and IL-17 in patients with psoriasis and psoriatic arthritis with concomitant metabolic syndrome.

Material and methods
This study included 60 patients with severe psoriasis.

Results
In patients with arterial hypertension concomitant with psoriasis, no statistically significant differences in cytokine levels were observed. On the other hand, in the group of patients diagnosed with diabetes, an increased level of IL-17 was observed. In patients with lipid disorders, the results were similar to the results of patients with diabetes.

Conclusions
It is very important to study immunologic mechanisms responsible for the presence and severity of psoriasis, in order to personalize the therapy in the future and optimize the effect of action on the basic disease and on concomitant disorders.

keywords:

Level of inflammatory cytokines tumour necrosis factor , interleukins 12, 23 and 17 in patients with psoriasis in the context of metabolic syndrome

Magdalena Pirowska , Katarzyna Podolec , Sylwia Lipko-Godlewska , Joanna Sułowicz , Paweł Brzewski , Aleksander Obtułowicz , Maciej Pastuszczak , Anna Wojas-Pelc

psoriasis, metabolic syndrome, cytokines

Magdalena Pirowska

,

Katarzyna Podolec

,

Sylwia Lipko-Godlewska

,

Joanna Sułowicz

,

Paweł Brzewski

,

Aleksander Obtułowicz

,

Maciej Pastuszczak

,

Anna Wojas-Pelc